Leader Electronics Inc. logo

Leader Electronics Inc. (3058)

Market Closed
15 Jun, 05:30
TWSE TWSE
NT$
9. 49
+0.27
+2.9284%
NT$
1.99B Market Cap
42.96 P/E Ratio
- Div Yield
674,555 Volume
5.94 Eps
NT$ 9.22
Previous Close
Add Transaction
Day Range
9.36 9.58
Year Range
8 13.8
Want to track 3058 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

3058 closed today higher at NT$9.49, an increase of 2.9284% from yesterday's close, completing a monthly increase of 9.0805% or NT$0.79. Over the past 12 months, 3058 stock lost -11.3084%.
3058 is not paying dividends to its shareholders.
The last earnings report, released on Jun 20, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.0731%, based on the last three reports.
Leader Electronics Inc. has completed 10 stock splits, with the recent split occurring on Feb 02, 2024.
The company's stock is traded on one exchange.

3058 Chart

People also search for

Asia Neo Tech Industrial Co., Ltd.
NT$ 360
+7.3025%
Roundtop Machinery Industries Co. Ltd.
NT$ 22.15
+1.8391%
IROC Co., Ltd.
NT$ 202
+1.5075%
International Ocean Group
NT$ 47.35
+8.3524%
JDV Control Valves Co., Ltd.
NT$ 39.9
+1.6561%

Leader Electronics Inc. (3058) FAQ

What is the stock price today?

The current price is NT$9.49.

On which exchange is it traded?

Leader Electronics Inc. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 3058.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.99B.

Has Leader Electronics Inc. ever had a stock split?

Leader Electronics Inc. had 10 splits and the recent split was on Feb 02, 2024.

Leader Electronics Inc. Profile

Electrical Equipment Industry
Industrials Sector
Mr. Chung-Yue Pao CEO
TWSE Exchange
TW0003058004 ISIN
TW Country
- Employees
3 Aug 2021 Last Dividend
2 Feb 2024 Last Split
- IPO Date

Overview

Formosa Laboratories, Inc., founded in 1985 and headquartered in Taoyuan, Taiwan, is a significant player in the pharmaceutical industry with a global reach, including countries like India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, and Canada. The company specializes in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers. Its operations are broad, encompassing not only the production of these critical components but also engaging in chemical trading and investment activities. Formosa Laboratories, Inc. aims to deliver high-quality products across various therapeutic areas through its extensive range of services and a commitment to innovation and excellence.

Products and Services

  • Active Pharmaceutical Ingredients (APIs)

    Formosa Laboratories, Inc. manufactures APIs for a variety of purposes, including anticancer treatments, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filters, treatments for iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, antibiotics, and many more areas. These ingredients are fundamental in the formulation of effective and safe pharmaceuticals.

  • Injectables

    The company produces injectable formulations in several therapeutic areas including IDA, MRI agents, oncology, and others. These injectables are developed using rigorous standards to ensure patient safety and therapeutic efficacy.

  • Contract Development and Manufacturing Services

    Formosa offers a suite of contract services including recrystallization, filtration, dialysis, column purification, distillation, spray drying, and micronization. Additionally, it provides injectable manufacturing along with secondary packaging, labeling, and serialization services, reflecting its capacity to cater to the comprehensive needs of pharmaceutical companies.

  • Custom Fermentation Services

    The company's custom fermentation services demonstrate its capabilities in utilizing microorganisms for the production of pharmaceutical products, a critical component of biotechnological manufacturing.

  • Peptide Synthesis Services

    Formosa Laboratories, Inc. offers peptide synthesis services, showcasing its expertise in creating specific and complex molecules that are pivotal in the development of novel therapeutics.

  • Antibody-Drug Conjugates Services

    This service range includes antibody development and manufacture, peptide and polymer drug conjugation, Linker-payload design, synthesis, and manufacturing, bio-conjugation and purification, cytotoxic liquid-filled and lyophilized product from pre-formulation studies to manufacture, and regulatory support. These services underline the company’s capabilities in the cutting-edge field of antibody-drug conjugates, which represent a significant advancement in targeted cancer therapies.

Contact Information

Address: No. 138, Baoqiao Road, New Taipei City, Taiwan, 23145
Phone: 886 2 8195 3058